Tag Archives: AVGO

AT&T Inc. Stock Is Still a Buy, But Investors Should Brace for Volatility

AT&T Inc. (NYSE:T) is the quintessential retirement play, and that’s likely not going to change anytime soon. But at the moment, T stock resembles a cryptocurrency, and not in a good way. Year-to-date, the telecom giant’s shares are down 10%. Although I still believe in its longer-term potential, prospective buyers should brace for more volatility.

All the drama surrounding AT&T stock, of course, has everything to do with the company’s proposed merger with Time Warner Inc (NYSE:TWX). If federal regulators approve the deal, it would be one of the biggest in American history.

Of course, in this politically charged environment, nothing is so simple. The Justice Department has sued to halt the merger, and we’re currently in the second week of the trial.

To assuage investors, InvestorPlace contributor Lawrence Meyers has written extensively about this case. To put it mildly, Meyers believes that the government is wasting its time.

He sees this as nothing more than entertaining showmanship, stating that “when the trial concludes, we will all be having a laugh at the Department of Justice’s expense. That assumes, of course, that the judge overseeing the trial doesn’t have a bout of unprecedented stupidity.”

A major reason why Meyers is so confident is that the Justice Department relies upon an invalid argument: that a vertical merger will incentivize AT&T Inc to deny certain channels to rival content distributors like Comcast Corporation (NASDAQ:CMCSA).

But that doom-and-gloom scenario won’t happen because AT&T would lose out on advertising and licensing revenue. Thus, T stock remains a compelling buy.

To be fair, the initial volley appears farcical. Justice Department attorneys resorted to sneaky courtroom tactics to sway the judge, which failed. A critical error almost caused their star witness to be struck.

Not Quite a Slam Dunk for T stock

I’m generally positive on AT&T stock, and I think with the market’s broader troubles, the telecom firm is on discount. But if you want a better entry point, patience is your friend.

Like Meyers, I believe that the merger will go through. But given some of the circumstances, I’m not nearly as confident. At the very least, I think we should take a step back and look at the trial objectively. We may realize the government’s case isn’t as crazy or stupid as it might initially appear.

The almost-struck witness is Warren Schlichting, programming executive from Dish Network Corp (NASDAQ:DISH). Schlichting made the expected testimony that having AT&T Inc own one of their best content providers represented an unfair impediment. Time Warner, using Schlichting’s words, is a “must have” in the television business.

He does have a point. Although streaming services like Netflix, Inc. (NASDAQ:NFLX) and Amazon.com, Inc. (NASDAQ:AMZN) provide great original content, it’s difficult to entirely replace “establishment” material. And while I very much enjoy YouTube content, most “vloggers” lack journalistic integrity.

My colleague might argue that DISH has nothing to worry about because AT&T will hurt itself if it denied programming. However, Schlichting seems to counteract that point, stating that “It is more lucrative to take subscribers than to collect programming fees.” If that’s true, the Justice Department’s case suddenly got more competitive.

We do have to acknowledge that Schlichting is obviously biased toward DISH. However, those extremely bullish on T stock make it appear as if this proposed vertical merger is a win-win for everyone. So just the fact that we have a major competitor complaining about it suggests not everything is rosy.

AT&T Stock Is Still a Buy, But Be Alert

We also must consider the Trump factor. Unless you’ve been in a coma, you know full well that President Trump hates Time Warner-owned CNN. He’s also threatened in the past to block this deal.

That sounds like a lot of hot air, and admittedly, we’ve seen much of that coming from the White House. Still, the commander in chief likes to keep people guessing. Bottom line: you can’t discount what he does or what kind of influence he can impose.

This isn’t to say that you should fear holding T stock. I love AT&T Inc for its long-haul fundamentals and its affordable (and generous) dividend yield. But we recently learned that “sure things” — the Broadcom Ltd (NASDAQ:AVGO) and Qualcomm, Inc. (NASDAQ:QCOM) failed merger comes to mind — aren’t always sure.

For me, you can still trust AT&T stock. However, you shouldn’t expect the next few weeks to be a cakewalk. Buy a little now, but keep the powder keg dry for a possibly greater discount later.

As of this writing, Josh Enomoto did not hold a position in any of the aforementioned securities.

Compare Brokers

Hot Medical Stocks To Own Right Now

CAPE CORAL, Fla. A company that makes artificial limbs offered to help a Florida woman who lost both of her legs as she tried to help a crash victim on Interstate 75.

Joshua Ryder, a certified orthotist and owner of Island Coast Orthopedics here, said he read about the plight of Danielle Hagmann, 30, of North Fort Myers, Fla., and wanted to help. Hagmann, who has no medical insurance, remains in the intensive care unit at Lee Memorial Hospital in Fort Myers, Fla., after having one leg amputated just above the knee and the other at mid-thigh.

Hagmann witnessed a one-car crash along I-75 during a heavy rainstorm early Sundayas she was returning from an outing with a former high school classmate.

While she was helping the crashed motorist, the driver of another car was unable to swerve away from the damaged car partially in the road’s right lane, pinning Hagmann’s legs between the car and the guardrail.

Hot Medical Stocks To Own Right Now: Umicore S.A. (UMICF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other major cobalt miners (note their focus is mostly on copper and nickel or other commodities) include Eurasian Resources Group (private), Umicore SA (OTCPK:UMICF), Lundin Mining (TSX:LUN) (OTCPK:LUNMF), MMC Norilsk Nickel (OTCPK:NILSY) (LSX:MNOD), Vale S.A. (NYSE:VALE), BHP (NYSE:BHP), Jinchuan Group International Resources Co Ltd (HK:2362).

Hot Medical Stocks To Own Right Now: One Horizon Group, Inc.(OHGI)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11

Hot Medical Stocks To Own Right Now: Flowers Foods, Inc.(FLO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Dr Pepper Snapple Group Inc. (NYSE: DPS) to report quarterly earnings at $1.06 per share on revenue of $1.57 billion before the opening bell. Dr Pepper Snapple shares fell 0.07 percent to close at $93.49 on Monday.
    Analysts expect American International Group Inc (NYSE: AIG) to post quarterly earnings at $1.01 per share on revenue of $12.87 billion after the closing bell. AIG shares gained 0.38 percent to $66.39 in after-hours trading.
    Flowers Foods, Inc. (NYSE: FLO) reported in-line earnings for its fourth quarter, while sales missed expectations. Flowers Foods shares fell 1.87 percent to $20.45 in the after-hours trading session.
    Before the markets open, Diebold Nixdorf Inc (NYSE: DBD) is projected to report its quarterly earnings at $0.32 per share on revenue of $1.31 billion. Diebold Nixdorf shares slipped 0.73 percent to close at $27.20 on Monday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Dan Caplinger]

    Consumers across the nation know Flowers Foods (NYSE:FLO) from its Wonder bread, Tastykake snack cakes, and Nature’s Own bakery brands. Yet the truly novel thing about Flowers is how it has done such a good job of building up a national presence in an industry that is typically dominated by local competition. Coming into Monday’s fourth-quarter financial report, Flowers investors were hoping to see at least some growth in sales and earnings, but the bakery company wasn’t able to deliver the pace of expansion that most shareholders really want to see.

Hot Medical Stocks To Own Right Now: Avago Technologies Limited(AVGO)

Advisors’ Opinion:

  • [By Lee Jackson]

    Private equity giant Silver Lake also continued to sell shares of a big technology position. The company sold a million shares of Broadcom Ltd. (NASDAQ: AVGO) at prices that ranged from $210.06 to $212.26. The total for the sale was a staggering $200 million. Shares ended the week at 210.37. The 52-week range is $132.25 to $215.96. The consensus price objective is $218.87.

  • [By Lisa Levin]

    Technology sector was the top gainer in the US market on Friday. Top gainers in the sector included LivePerson, Inc. (NASDAQ: LPSN), Vicor Corp (NASDAQ: VICR), and Broadcom Ltd (NASDAQ: AVGO).

  • [By WWW.THESTREET.COM]

    Shares rose 6.3% after hours to $159.50, and made fresh highs. They’re now up 37% on the year. iPhone/iPad suppliers also got a boost: Cirrus Logic Inc. (CRUS)  rose 4.2% to $65.70, Skyworks Solutions Inc. (SWKS)  rose 3.1% to $107.50, Qorvo Inc.  (QRVO) rose 2.7% to $69.90, Jabil Inc.  (JBL) rose 1.2% to $30.78 and Broadcom Ltd. (AVGO)  rose 2.8% to $255.40.

  • [By Harsh Chauhan]

    More importantly, Apple could build around 120 million new iPhones this year as compared to 89 million units of the iPhone 7/7S in 2016 — according to Mizuho. This is great news for the other companies in Cupertino’s supply chain — such as Skyworks Solutions (NASDAQ:SWKS), Broadcom (NASDAQ:AVGO), and Cypress Semiconductor (NASDAQ:CY) — as they won’t have to wait until the second half of the year to bask in iPhone-driven glory.

  • [By Chris Lange]

    Broadcom Ltd. (NASDAQ: AVGO) short interest fell to 3.97 million shares in the period, from the previous of 4.43 million. Shares closed most recently at $176.75, in a 52-week range of $114.25 to $179.42.

Best Value Stocks To Buy Right Now

Facebook has hired a former television journalist to help improve its relationship with news organizations.

Campbell Brown, a former NBC News correspondent and CNN host who went on to become an advocate for school reform, will serve as Facebook’s head of news partnerships, the company announced Friday.

In that role, Brown will be the liaison between Facebook and news organizations, which have grown increasingly concerned about the social media giant’s ability to exploit their content. While news organizations rely on Facebook for distribution to its audience of nearly 2 billion users, more and more of those eyeballs are accessing that content exclusively on Facebook, hurting the media industry’s ad revenue.

“I will be working directly with our partners to help them understand how Facebook can expand the reach of their journalism, and contribute value to their businesses,” Brown said in a post on her Facebook page. “That also means making sure there is ongoing feedback from publishers as Facebook develops new products and tools for news organizations.”

Best Value Stocks To Buy Right Now: The Rubicon Project, Inc.(RUBI)

Advisors’ Opinion:

  • [By Paul Ausick]

    Rubicon Project Inc. (NYSE: RUBI) dropped about 29% Wednesday to post a new 52-week low of $5.96 after closing Tuesday at $8.39. Volume of more than 6.1 million shares was more than 10 times the daily average of less than 600,000. The company named a new CEO and reported weak results after markets closed Tuesday.

  • [By Lisa Levin]

    The Rubicon Project Inc (NYSE: RUBI) shares dropped 28 percent to $6.08. Rubicon Project reported upbeat results for its fourth quarter and named Michael Barrett as CEO.

  • [By Paul Ausick]

    Rubicon Project Inc. (NYSE: RUBI) dropped about 1.9% Friday, to post a new 52-week low of $5.65 after closing at $5.76 on Thursday. The stock’s 52-week high is $20.37. Volume was nearly 4 times the daily average of around 740,000 shares. The company had no specific news.

  • [By Paul Ausick]

    The Rubicon Project Inc. (NYSE: RUBI) dropped about 2.4% on Tuesday to post a new 52-week low of $8.64 against a 52-week high of $20.37. Volume of around 680,000 million was about 15% below the daily average of around 780,000. The stock closed at $8.85 on Monday night. The ad marketplace has formed a strategic alliance with Flipboard that will allow advertisers to buy ad space on Flipboard.

Best Value Stocks To Buy Right Now: Cherokee Inc.(CHKE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cherokee Inc (NASDAQ: CHKE) shares dropped 32 percent to $5.26 after the company reported a loss for its first quarter on Thursday. The company reported an adjusted loss of $0.07 per share, versus analysts’ estimates for a profit of $0.13 per share.

  • [By Lisa Levin]

    Cherokee Inc (NASDAQ: CHKE) shares dropped 37 percent to $4.85 after the company reported a loss for its first quarter on Thursday. The company reported an adjusted loss of $0.07 per share, versus analysts’ estimates for a profit of $0.13 per share.

Best Value Stocks To Buy Right Now: Century Aluminum Company(CENX)

Advisors’ Opinion:

  • [By Craig Jones]

    JPMorgan’s analyst Michael Gambardella downgraded Century Aluminum Co (NASDAQ: CENX) from Overweight to Neutral and reduced its price target from $22 to $14.50, citing alumina cost headwinds as the main reason for the downgrade.

Best Value Stocks To Buy Right Now: Herman Miller, Inc.(MLHR)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Herman Miller Inc. (NASDAQ: MLHR) was raised to Market Perform from Underperform at Raymond James.

    Kroger Co. (NYSE: KR) was raised to Outperform from Sector Perform at RBC Capital Markets.

  • [By Monica Gerson]

    Herman Miller, Inc. (NASDAQ: MLHR) is projected to post its quarterly earnings at $0.39 per share on revenue of $544.40 million.

    Ctrip.com International, Ltd. (ADR) (NASDAQ: CTRP) is estimated to post a quarterly loss at $0.09 per share on revenue of $2.81 billion.

  • [By Lisa Levin]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Analysts are expecting Com

Best Value Stocks To Buy Right Now: Avago Technologies Limited(AVGO)

Advisors’ Opinion:

  • [By Harsh Chauhan]

    More importantly, Apple could build around 120 million new iPhones this year as compared to 89 million units of the iPhone 7/7S in 2016 — according to Mizuho. This is great news for the other companies in Cupertino’s supply chain — such as Skyworks Solutions (NASDAQ:SWKS), Broadcom (NASDAQ:AVGO), and Cypress Semiconductor (NASDAQ:CY) — as they won’t have to wait until the second half of the year to bask in iPhone-driven glory.

  • [By Timothy Green]

    Semiconductor company Broadcom (NASDAQ:AVGO) reported its fiscal first-quarter results after the market close on March 1. Revenue soared compared to the first quarter of 2016 thanks to the Broadcom-Avago merger, but sequential revenue growth was weighed down by sluggishness in the wired infrastructure and wireless communications segments. Here’s what investors need to know about Broadcom’s first-quarter results.

  • [By WWW.THESTREET.COM]

    In gainers, Broadcom (AVGO) shares added 4.15%, to 177.80, after the chipmaker posted better-than-anticipated results for its fiscal 2016 fourth quarter and full year as it reaps the benefits from the combination with Avago.

Uncertainties Abound With QUALCOMM, Inc. Stock Price

After a few years in the wilderness, QUALCOMM, Inc. (NASDAQ:QCOM) has become one of the more interesting stocks in the market. The QCOM stock price has gained almost 30% just since late October, thanks mostly to a buyout offer from Broadcom Ltd (NASDAQ:AVGO).

Of course, those gains followed a difficult 2017, highlighted by a legal battle against Apple Inc. (NASDAQ:AAPL). The QCOM stock price actually remains modestly negative this year. All the while, Qualcomm has been trying to close its $47 billion acquisition of NXP Semiconductors NV (NASDAQ:NXPI), while activist Elliot Advisors (UK) is fighting for a higher price.

There’s a lot to unpack here. But at first blush, it would seem QCOM stock has more upside. After all, Broadcom’s initial, albeit rejected, offer was for $70 per share, mostly in cash. Yet the QCOM stock price sits below $65 — with a second offer from Broadcom highly likely, as Luke Lango argued this week.

But from here, $64+ looks about right. The drama at NXP could complicate matters. Qualcomm hasn’t shown any interest in a takeover. Broadcom is gearing up for what would be a huge proxy fight, and even an agreed-to deal will face a lengthy regulatory review.

Given not only the risks involved with a buyout, but also the time it would take to actually close, the upside in the QCOM stock price probably is much, much less than it appears. And that suggests moving to the sidelines as Qualcomm figures out its next steps.

Is a Second Offer Coming?

Lango estimated the probability of a second offer from Broadcom at 75% — but I actually think that estimate is low. The QCOM stock price is just above $64. Broadcom’s initial offer was for $70 per share, with $10 per share of that in cash.

Assuming Qualcomm had accepted that offer, it’s likely QCOM still would be in the $65 range. That $70 from AVGO would no doubt take at least a year for shareholders to receive, which alone knocks ~5-6% off the present value. Add the risk of the deal failing and it’s possible that the QCOM stock price would be lower than the current $64 if it had agreed to a deal.

A good parallel is the acquisition of Aetna Inc (NYSE:AET) by CVS Health Corp (NYSE:CVS). CVS’ headline offer was for $207 per share, yet AET trades at just $181 right now — a 13% discount to that price. QCOM’s discount to the offer would likely be narrower, but the discount would still exist.

My broader point here is that Qualcomm is presently trading at about the same level it would have had it accepted the deal — which it didn’t. Yet, Broadcom has launched a proxy fight, nominating 11 directors to the Qualcomm board. There’s almost no way the company would make that move without expecting a higher offer, because few shareholders would be interested in taking the current one. Any shareholder voting “yes” for Broadcom nominees would be running the risk of sending the share price lower or, at best, capping the near-term upside.

Will Qualcomm Accept?

It’s illogical for Broadcom to start a proxy fight without a higher bid in its pocket. Speculation suggests that the new bid will be in the $80 range, but, whatever it is, logic dictates that it will have to be notably higher than the initial bid for this process to move forward.

The question is whether Qualcomm will accept. According to the proxy statement filed by Broadcom, Broadcom CEO Hock Tan met with Qualcomm CEO Steve Mollenkopf twice in 2016 to discuss a potential combination. After an early 2017 phone call, Mollenkopf said he “would reflect on the matter and then get back to Mr. Tan.”

He never did.

In short, Qualcomm wasn’t interested in a deal. In fact, less than two months after the second meeting with Tan, Mollenkopf announced the NXPI acquisition, which, given its size, might even be seen as a bulwark against Broadcom’s interest.

So far, there’s no evidence Qualcomm has changed its mind about selling. And it’s worth noting that NXP could be a monkey wrench. Broadcom’s deal is valid whether or not Qualcomm closes that acquisition — but only if the purchase “is consummated on the currently disclosed terms of $110 per share.”

What This All Means for the QCOM Stock Price

So, the problem for the QCOM stock price in 2018 is going to be just how many moving parts there are. Even assuming Broadcom is willing to offer $85/share, Qualcomm has to accept that offer. It has to get the NXPI deal done at $110/share — or convince Broadcom to change the terms of its offer. With NXPI trading near $117, the market clearly thinks the original price is unlikely. And, then, what would be the largest tech deal in history has to pass regulatory muster.

It’s a lot to ask and it will take time. Admittedly, the Qualcomm dividend likely would mitigate some of the cost of waiting, as, at $80/share, Qualcomm investors still would receive almost a 3% yield. Even with that, however, assuming a deal closes in mid-2019 at $85/share would value QCOM stock, right now, at about $77. A deal break probably values the stock in the low-$50s, back toward levels seen before the Broadcom deal was announced.

That, in turn, suggests the market is pricing in a 40-50% chance of the deal going through — which seems about right. $85 might be too much for Broadcom to pay. NXP could scuttle the deal if Qualcomm is intent on making that purchase. Qualcomm may not be interested in a Broadcom tie-up. And any bad news on the legal front with Apple adds another layer of risk.

From here, the fact that the QCOM stock price has settled so far in December makes some sense. Based on what we know, the price looks about right. With a lot more news coming in 2018, that price no doubt will change.

It’s predicting the direction of that change that’s the hard part.

As of this writing, Vince Martin has no positions in any securities mentioned.

Compare Brokers

stock market simulator

This article is reprinted by permission from NextAvenue.org.

Managing your money is hard enough. But what if your income fluctuates so much that for more than five months of the year, its 25% above or below your monthly average? That kind of roller-coaster financial insecurity is exactly what the authors of the new book The Financial Diaries discovered while tracking the lives of 470 low- and moderate-income Americans in 235 households.

stock market simulator: New York Community Bancorp, Inc.(NYCB)

Advisors’ Opinion:

  • [By Paul Ausick]

    New York Community Bank Inc. (NYSE: NYCB) dropped 5% Wednesday to post a new low of $13.05 after closing at $13.74 Tuesday night. The stock’s 52-week high is $17.68. Volume was about 80% above the daily average of around 4.8 million shares. The bank reported disappointing results this morning.

stock market simulator: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Keith Speights, Sean Williams, and Cory Renauer]

    So when we asked three of our top healthcare contributors to name three of the best stocks to invest in healthcare, it’s not surprising that their responses listed companies in three different industries: medical device makerMasimo (NASDAQ:MASI), pharmacy services giant CVS Health (NYSE:CVS) and biopharmaceutical company Ligand Pharmaceuticals (NASDAQ:LGND). Here’s why these three healthcare stocks stand out as smart picks.

  • [By Keith Speights]

    Research and development is the lifeblood of biotech companies. The potential for new drugs also serves as a primary factor driving biotech stocks higher and higher. That’s been the case for Celgene (NASDAQ:CELG), Ionis Pharmaceuticals (NASDAQ:IONS), and Ligand Pharmaceuticals (NASDAQ:LGND).

stock market simulator: Avago Technologies Limited(AVGO)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In gainers, Broadcom (AVGO) shares added 4.15%, to 177.80, after the chipmaker posted better-than-anticipated results for its fiscal 2016 fourth quarter and full year as it reaps the benefits from the combination with Avago.

  • [By Lisa Levin]

    Technology sector was the top gainer in the US market on Friday. Top gainers in the sector included LivePerson, Inc. (NASDAQ: LPSN), Vicor Corp (NASDAQ: VICR), and Broadcom Ltd (NASDAQ: AVGO).

  • [By Harsh Chauhan]

    More importantly, Apple could build around 120 million new iPhones this year as compared to 89 million units of the iPhone 7/7S in 2016 — according to Mizuho. This is great news for the other companies in Cupertino’s supply chain — such as Skyworks Solutions (NASDAQ:SWKS), Broadcom (NASDAQ:AVGO), and Cypress Semiconductor (NASDAQ:CY) — as they won’t have to wait until the second half of the year to bask in iPhone-driven glory.

  • [By WWW.THESTREET.COM]

    The same case is made for Action Alerts PLUS holding Alphabet (GOOGL) and for Lam Research (LRCX) and Broadcom (AVGO) and Growth Seeker holding Amazon (AMZN) –and a host of other high-growth companies.

stock market simulator: Fossil Inc.(FOSL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Fossil Group Inc (NASDAQ: FOSL) was down, falling around 21 percent to $14.32 after the company posted downbeat quarterly results and issued a weak outlook for the second quarter.

  • [By Paul Ausick]

    Fossil Group Inc. (NASDAQ: FOSL) dropped nearly 21% Wednesday, to post a new 52-week low of $18.10 after closing at $22.87 on Tuesday. The stock’s 52-week high is $51.93. Volume was about 15 times the daily average of around 1.2 million shares. The company reported so-so results last night and Wells Fargo cut its rating on the stock to Underperform this morning.

  • [By Paul Ausick]

    Fossil Group Inc. (NASDAQ: FOSL) dropped about 5.4% Thursday, to post a new 52-week low of $22.78 after closing at $24.07 on Wednesday. The stock’s 52-week high is $51.93. Volume was about 3 times the daily average of around 1.1 million shares. The company had no specific news, but the troubles at Fitbit may be spilling over.

  • [By WWW.THESTREET.COM]

    Fossil is in deep trouble: As mentioned earlier in the week, Fossil (FOSL) came out with more big plans for the smartwatch market at Basel World. Unfortunately, as TheStreet reported, the company is fighting an uphill battle with Apple and could be in big trouble.